Based on the available info, this event is deemed to be a serious injury.Current skincare includes using sensicare adhesive releaser; sensicare adhesive remover; water; and eakin.The end user is applying topical clobetasol propionate cream to peristomal rash which is covered with duoderm extra thin just in the last twelve (12) hours.The end user was instructed on appropriate skin care and will cut away tape collar and sample active life (al) convex urostomy appliance.End user was encouraged to follow up with a health care professional (hcp) if concerns persist or worsen.She is using marlen product to manage ileostomy.No patient/event details has been provided to date.Should additional info become available, a follow-up report will be submitted.
|
The product associated with batch 3a01849 was made according to specification.After detailed batch review, no discrepancies (includes non-conformances/deviations) were found.This complaint is not associated with a product malfunction.The complaint/incidence data-post market data analysis (trend analysis), clinical review, root cause analysis and risk assessment indicate a consistent rate of complaints as a result of skin complications which are caused by a variety of external factors not related to the design, materials, and/or processes of the product.No further actions are required, and this complaint will be closed.Product monitoring reviews will monitor for product trends if this issue were to reoccur.(b)(4).No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.Reported to the fda on march 14, 2016.(b)(4).
|